[Chronic viral hepatitis].
V V
VV
Serov
Z G
ZG
Aprosina
T M
TM
Ignatova
P E
PE
Krel'
S M
SM
Sekamova
E L
EL
Tanashchuk
A A
AA
Il'iankova
D000328:Adult; D000367:Age Factors; D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D004796:Clinical Enzyme Tests; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006513:Hepatitis B e Antigens / Q000032:analysis; D019694:Hepatitis B, Chronic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors
D000998:Antiviral Agents; D005938:Glucocorticoids; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D012254:Ribavirin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase